The availability of safe, effective COVID vaccines less than a year into the pandemic marked a high point in the 300-year ...
The availability of safe, effective COVID vaccines less than a year into the pandemic marked a high point in the 300-year ...
The availability of safe, effective covid vaccines less than a year into the pandemic marked a high point in the 300-year ...
Scott Gottlieb, who was Trump’s first FDA commissioner, said on CNBC on Nov. 29 that Kennedy “will cost lives in this country ...
The way America thinks about health care is terribly wrong. The Centers for Disease Control and Prevention report that a ...
Robert F. Kennedy Jr.’s appointment last month to lead the U.S. Department of Health and Human Services (HHS) immediately ...
Scott Gottlieb, who served early on in Trump's first term, is now warning senators about the impact Kennedy could have on ...
The breast cancer drug Enhertu will be added to China’s national health insurance scheme beginning in the new year — despite ...
Dr. Scott Gottlieb, Trump’s former FDA commissioner, said he has concerns about the president-elect’s pick for health ...
Trump’s team considered O’Neill to lead the FDA in his first term before picking Scott Gottlieb. Eric Hargan, a Bush-era health official who Trump then nominated to fill the HHS deputy ...
At the same time, the company he founded, Roivant Sciences, is pursuing studies for three drugs that, if positive, could land before the FDA during Trump’s second term. His stock in Roivant is ...
Bush administration such as Scott Gottlieb, his first FDA commissioner, who brought experience preparing for pandemic flu. The contrast is most striking atop HHS, a nearly $2 trillion agency that ...